SCHEMBL21391472

SCHEMBL21391472

CNC(=O)c1cccc(O)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.50
GAA P10253 2/20 0.48
TSHR P16473 2/20 0.43
FADS1 O60427 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MPO P05164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
P2RX7 Q99572 1/20 0.41
PDK2 Q15119 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3786271 0.88 PLK1 (0.57) PLK1GAATSHRTAS1R3TAS1R1
SCHEMBL4143751 0.82 TAS1R3 (0.60) PLK1GAATSHRTAS1R3TAS1R1
SCHEMBL31547716 0.81 TAS1R3 (0.54) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL7981657 0.81 TAS1R3 (0.54) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL2664419 0.81 MAPT (0.49) GAATSHRFADS1TAS1R3TAS1R1
SCHEMBL3365582 0.80 TERT (0.59) PLK1GAATSHRTAS1R3TAS1R1
SCHEMBL1799299 0.79 KDM4E (0.65) PLK1GAATSHRKDM4EMPO
SCHEMBL1742047 0.79 GAA (0.67) PLK1GAATAS1R3TAS1R1TAS1R2
SCHEMBL10156678 0.79 P2RX7 (0.50) PLK1GAAFADS1TAS1R3TAS1R1
SCHEMBL14164188 0.78 PLK1 (0.52) PLK1GAATSHRKDM4EMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047725-A1 CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2022-02-17 US disclosed
US-10660974-B2 Chemiluminescent probes for diagnostics and in vivo imaging RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2020-05-26 US disclosed
US-20190290787-A1 CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10660974-B2 Chemiluminescent probes for diagnostics and in vivo imaging DAXX, DCAF15, DCAF1 PLK1 4406/4885GAA 2770/4885TSHR 1960/4885
US-20220047725-A1 CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING DAXX, DCAF15, CDY1; CDY1B PLK1 4309/4885GAA 2453/4885TSHR 1343/4885
US-20190290787-A1 CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING DAXX, DCAF15, DCAF1 PLK1 4406/4885GAA 2770/4885TSHR 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.